IM8's $1 Billion 'Investment' Is A Revenue-Sharing Loan, Not Equity
General Catalyst's Customer Value Fund advances IM8 up to $1 billion for acquisition costs, repaid through a capped revenue share.
- IM8 sells a subscription vitamin drink with açai extract and Coenzyme Q10, co-founded by Beckham.
- General Catalyst finances up to 70% of IM8's customer acquisition costs under the deal.
- Grammarly took the same $1 billion non-dilutive loan from General Catalyst's CVF in May 2025.
Why it matters: General Catalyst is not betting on IM8's health claims, only on its advertising math turning a profit.
TechCrunch ↗ · Jul 17, 20267/17/26 · ✓ Checked✓ Check